SI1651644T1 - Substituirani tiazol-benzoizotiazol dioksidni derivati, postopek za njihovo pripravo in njihova uporaba - Google Patents

Substituirani tiazol-benzoizotiazol dioksidni derivati, postopek za njihovo pripravo in njihova uporaba

Info

Publication number
SI1651644T1
SI1651644T1 SI200430126T SI200430126T SI1651644T1 SI 1651644 T1 SI1651644 T1 SI 1651644T1 SI 200430126 T SI200430126 T SI 200430126T SI 200430126 T SI200430126 T SI 200430126T SI 1651644 T1 SI1651644 T1 SI 1651644T1
Authority
SI
Slovenia
Prior art keywords
production
same
substituted thiazole
dioxide derivatives
benzoisothiazole
Prior art date
Application number
SI200430126T
Other languages
English (en)
Slovenian (sl)
Inventor
Stefan Petry
Karl-Heinz Baringhaus
Norbert Tennagels
Guenter Mueller
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of SI1651644T1 publication Critical patent/SI1651644T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SI200430126T 2003-07-28 2004-07-15 Substituirani tiazol-benzoizotiazol dioksidni derivati, postopek za njihovo pripravo in njihova uporaba SI1651644T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10334309A DE10334309A1 (de) 2003-07-28 2003-07-28 Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP2004/007847 WO2005012295A1 (de) 2003-07-28 2004-07-15 Substituierte thiazol-benzoisothiazoldioxidderivative, verfahren zu deren herstellung und deren verwendung
EP04741034A EP1651644B1 (de) 2003-07-28 2004-07-15 Substituierte thiazol-benzoisothiazoldioxidderivative, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
SI1651644T1 true SI1651644T1 (sl) 2007-02-28

Family

ID=34111694

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430126T SI1651644T1 (sl) 2003-07-28 2004-07-15 Substituirani tiazol-benzoizotiazol dioksidni derivati, postopek za njihovo pripravo in njihova uporaba

Country Status (37)

Country Link
EP (1) EP1651644B1 (enExample)
JP (1) JP2007500145A (enExample)
KR (1) KR20060052886A (enExample)
CN (1) CN100413862C (enExample)
AR (1) AR045113A1 (enExample)
AT (1) ATE346065T1 (enExample)
AU (1) AU2004261370B2 (enExample)
BR (1) BRPI0412997A (enExample)
CA (1) CA2533673A1 (enExample)
CR (1) CR8202A (enExample)
CY (1) CY1105962T1 (enExample)
DE (2) DE10334309A1 (enExample)
DK (1) DK1651644T3 (enExample)
EC (1) ECSP066326A (enExample)
ES (1) ES2276319T3 (enExample)
GT (1) GT200400146A (enExample)
IL (1) IL173289A0 (enExample)
JO (1) JO2449B1 (enExample)
MA (1) MA27932A1 (enExample)
MY (1) MY141197A (enExample)
NO (1) NO20060908L (enExample)
NZ (1) NZ544975A (enExample)
OA (1) OA13198A (enExample)
PA (1) PA8607201A1 (enExample)
PE (1) PE20050326A1 (enExample)
PL (1) PL1651644T3 (enExample)
PT (1) PT1651644E (enExample)
RS (1) RS20060015A (enExample)
RU (1) RU2350613C2 (enExample)
SA (1) SA04250332B1 (enExample)
SI (1) SI1651644T1 (enExample)
TN (1) TNSN06030A1 (enExample)
TW (1) TW200524923A (enExample)
UA (1) UA83057C2 (enExample)
UY (1) UY28443A1 (enExample)
WO (1) WO2005012295A1 (enExample)
ZA (1) ZA200510378B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004026532A1 (de) * 2004-05-29 2006-01-05 Sanofi-Aventis Deutschland Gmbh Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
RU2456273C2 (ru) * 2006-03-31 2012-07-20 Новартис Аг Новые соединения
CA2666193A1 (en) 2006-08-08 2008-02-14 Sanofi-Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AR072707A1 (es) 2008-07-09 2010-09-15 Sanofi Aventis Compuestos heterociclicos, procesos para su preparacion, medicamentos que comprenden estos compuestos y el uso de los mismos
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
PT2470552E (pt) 2009-08-26 2014-01-30 Sanofi Sa Novos hidratos de fluoroglicósido heteroaromáticos cristalinos, fármacos compreendendo estes compostos e sua utilização
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2012120055A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8846666B2 (en) 2011-03-08 2014-09-30 Sanofi Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2683700B1 (de) 2011-03-08 2015-02-18 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120051A1 (de) 2011-03-08 2012-09-13 Sanofi Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8901114B2 (en) 2011-03-08 2014-12-02 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8895547B2 (en) 2011-03-08 2014-11-25 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8809324B2 (en) 2011-03-08 2014-08-19 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2025017207A1 (en) * 2023-07-20 2025-01-23 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh Inhibitors of smndc1 and their therapeutic use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539584A (en) * 1967-11-14 1970-11-10 Colgate Palmolive Co 5-substituted-2,1-benzisothiazolines
JPH04128276A (ja) * 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途
AU699367B2 (en) * 1995-06-02 1998-12-03 Sanofi-Aventis Isoindole derivatives, their preparation and their application in therapy
CO5190696A1 (es) * 1999-06-16 2002-08-29 Smithkline Beecham Corp Antagonistas de los receptores il-8
DE10038709A1 (de) * 2000-08-09 2002-02-28 Aventis Pharma Gmbh Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen

Also Published As

Publication number Publication date
DE502004002117D1 (de) 2007-01-04
TW200524923A (en) 2005-08-01
IL173289A0 (en) 2006-06-11
NO20060908L (no) 2006-02-24
UA83057C2 (ru) 2008-06-10
SA04250332B1 (ar) 2008-02-25
WO2005012295A1 (de) 2005-02-10
DK1651644T3 (da) 2007-03-26
AR045113A1 (es) 2005-10-19
OA13198A (en) 2006-12-13
PL1651644T3 (pl) 2007-03-30
ZA200510378B (en) 2006-11-29
JP2007500145A (ja) 2007-01-11
PE20050326A1 (es) 2005-06-16
CN100413862C (zh) 2008-08-27
MA27932A1 (fr) 2006-06-01
NZ544975A (en) 2010-02-26
KR20060052886A (ko) 2006-05-19
MY141197A (en) 2010-03-31
RU2350613C2 (ru) 2009-03-27
RU2006106231A (ru) 2006-06-27
EP1651644A1 (de) 2006-05-03
AU2004261370A1 (en) 2005-02-10
PA8607201A1 (es) 2005-03-03
HK1091825A1 (en) 2007-01-26
PT1651644E (pt) 2007-01-31
ECSP066326A (es) 2006-07-28
JO2449B1 (en) 2008-10-09
CN1829715A (zh) 2006-09-06
DE10334309A1 (de) 2005-03-03
EP1651644B1 (de) 2006-11-22
RS20060015A (sr) 2007-12-31
ES2276319T3 (es) 2007-06-16
UY28443A1 (es) 2005-02-28
CY1105962T1 (el) 2011-04-06
AU2004261370B2 (en) 2009-07-16
TNSN06030A1 (en) 2007-10-03
BRPI0412997A (pt) 2006-10-03
ATE346065T1 (de) 2006-12-15
CR8202A (es) 2008-10-15
CA2533673A1 (en) 2005-02-10
GT200400146A (es) 2005-08-12

Similar Documents

Publication Publication Date Title
IL173289A0 (en) Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same
HRP20040930A2 (en) Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
PL378065A1 (pl) Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych
IL173204A0 (en) Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
PL378168A1 (pl) Dihydropterydynony, sposoby ich wytwarzania i ich zastosowanie w postaci leków
IL196010A0 (en) Pyrazole derivatives and process for the production thereof
IL197312A0 (en) Amyloid-??(1-42) oligomers, derivatives thereof antibodies for the same, method for production and use thereof
AU2003266194A8 (en) Nanocomposite, method for production and use thereof
IL179758A0 (en) Substituted tetrahydro - 2h - isoquinolin - 1 - one derivatives, method for the production thereof, and use of the same as medicaments
IL174405A0 (en) 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
IL179424A0 (en) Substituted oxazole -benzoisothiazole dioxide derivatives, process for their preparation and their use
PL377741A1 (pl) Pochodne diarylocykloalkilowe, sposób ich wytwarzania i ich zastosowanie jako środka leczniczego
PL371319A1 (en) Coumarin derivatives, process for their production and use thereof
AU2003303735A1 (en) Oligomer silasesquioxanes, method for the production thereof, and use of the same
PL371317A1 (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
PL366690A1 (en) New derivatives of 4,5,6,7-tetrabromobenzimidazole and method for their obtaining
PT1663997E (pt) 1h-azolilmetilamidas, processos para a sua produção e a sua utilização como inibidores de nitrificação
IL174975A0 (en) 2-phenyl-benzofuran derivatives, method for the production thereof and their use
PL376753A1 (pl) Podstawione pochodne 3-(benzoiloureido)-tiofenu, sposób ich wytwarzania oraz ich zastosowanie
AU2003264134A1 (en) Sarcolysyl derivatives and method for the production thereof
IL173447A0 (en) Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
IL174524A0 (en) Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer
PL373599A1 (en) Method for the production of monoalkylamino ketones
IL157793A0 (en) Caloporoside derivatives, methods for the production thereof and their use